What does Cannabis Sativa Extract (CBD) do?

Hemp-derived extract with early pain and anti-inflammatory research, but human evidence is very limited.

Is Cannabis Sativa Extract (CBD) safe?

Nearly all evidence in the provided studies is from animal models — human data is extremely thin

Cannabis Sativa Extract (CBD) - Science-Based Research

What the Science Says

Cannabis sativa extract contains cannabidiol (CBD) and other phytocannabinoids that interact with the body's endocannabinoid system. Animal research suggests it may reduce neuropathic pain and inflammation by activating CB2 receptors, which are involved in immune and pain signaling. Human clinical data from the provided studies is extremely limited — only one small pharmacokinetics study (11 participants) was available, meaning real-world dosing and effectiveness in people remain largely unestablished.

What It Doesn't Do

Not proven to treat chronic pain in humans based on available data. No human evidence here for anxiety, sleep, or cancer treatment despite widespread marketing claims. Animal results don't automatically translate to people. A single pharmacokinetics study tells us nothing about whether it actually works for any health condition.

Evidence-Based Benefits

Cannabis sativa extract contains cannabidiol (CBD) and other phytocannabinoids that interact with the body's endocannabinoid system. Animal research suggests it may reduce neuropathic pain and inflammation by activating CB2 receptors, which are involved in immune and pain signaling. Human clinical data from the provided studies is extremely limited — only one small pharmacokinetics study (11 participants) was available, meaning real-world dosing and effectiveness in people remain largely unestablished.

Weak Evidence

Effective at: No established dose from provided studies

Source: auto-research

Absorption & Bioavailability

Poor to Moderate when taken orally — highly variable. One human study found that eating a high-fat meal significantly increases CBD absorption compared to fasting. Without food, oral bioavailability is low and inconsistent.

Red Flags to Watch For

Nearly all evidence in the provided studies is from animal models — human data is extremely thin
Bioavailability varies dramatically depending on whether taken with food, making dosing unreliable without standardization
Fertility concerns flagged in preclinical rat studies — reproductive safety in humans is not established
Combined CBD and THC toxicity data described as 'inconclusive' in provided safety research
Over 1,000 registered supplement products exist despite very limited clinical evidence — heavy marketing outpaces the science
Product quality and actual CBD content vary widely across the supplement market with limited regulatory oversight

Research Sources

PubMed
NIH DSLD